Phenobarbital NDC 70752-166

NDC codes

FDA NDC Directory

Product NDC (as listed)70752-166Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70752-0166Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70752-166-10	70752016610	100 TABLET in 1 BOTTLE (70752-166-10)Marketed from Sep 30, 2020
70752-166-11	70752016611	1000 TABLET in 1 BOTTLE (70752-166-11)Marketed from Sep 30, 2020
70752-166-14	70752016614	500 TABLET in 1 BOTTLE (70752-166-14)Marketed from Sep 30, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phenobarbital
Generic name (nonproprietary): phenobarbital
Active ingredients: Phenobarbital — 30 mg/1
Dosage form: Tablet
Route: Oral
Labeler: QUAGEN PHARMACEUTICALS LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Sep 30, 2020
Listing expires: Dec 31, 2026
DEA schedule: CIV
Identifiers: Product ID 70752-166_b9516314-0ea2-46f0-9354-20bd0bb54e4aSPL ID b9516314-0ea2-46f0-9354-20bd0bb54e4aSPL set ID 81930c69-d073-402a-9089-ae891bfddc25RxCUI 198083, 198089, 312357, 312362UNII YQE403BP4D

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470752016610 followed by a unit qualifier and the quantity

Package 70752-0166-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 16, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Phenobarbital Tablets, USP are indicated for use as a sedative or anticonvulsant.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)